A compound production device for a transdermal patch slow-release layer
By introducing a mixing assembly with side wall scrapers and bottom scrapers, along with a flexible pressure regulating assembly driven by a hydraulic rod, into the transdermal patch production equipment, the problems of uneven drug mixing and rigid compound pressure regulation were solved, achieving uniform drug mixing and consistent compound thickness, thus improving product quality.
Patent Information
- Application Number
- CN202522636629.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-12
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2035-12-12
AI Technical Summary
Existing transdermal patch production equipment suffers from uneven drug distribution during the drug mixing process, and the pressure adjustment of the composite roller is rigid and lacks a buffering mechanism, resulting in unstable product efficacy and low pass rate.
The mixing assembly, which includes side wall scrapers and bottom scrapers, is combined with a hydraulically driven flexible pressure regulating assembly. The mixing roller scrapes the drug from the inner wall and bottom of the mixing tank, and the hydraulic rod and spring work together to provide flexible pressure regulation, ensuring uniform drug mixing and adapting to changes in material thickness.
It achieves comprehensive and seamless mixing of drugs, improving drug uniformity, and ensures consistent composite thickness through flexible pressure adjustment, thereby enhancing the efficacy and pass rate of the product.
Smart Images

Figure CN224975337U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of medical device manufacturing technology, and in particular to a composite production equipment for a transdermal patch sustained-release layer for pharmaceutical use. Background Technology
[0002] Transdermal patches for pharmaceuticals are an important route of drug delivery, and their production process typically involves the preparation and lamination of a drug-releasing layer. The manufacturing process first requires thorough mixing of the active pharmaceutical ingredient with a polymer matrix, then coating the mixture onto a substrate, and finally covering it with a protective film and pressing it together.
[0003] However, existing transdermal patch production equipment has some significant shortcomings in practical use. In the drug mixing stage, because the polymer matrix typically has high viscosity, ordinary stirring devices struggle to move the edge material, easily creating dead zones on the inner wall and bottom of the mixing container. This results in uneven drug distribution, directly affecting the patch's efficacy and batch stability. Furthermore, in the subsequent lamination stage, existing pressing mechanisms often use lead screws or cylinders to directly drive pressure rollers for rigid extrusion. This method lacks a buffering mechanism; when the substrate thickness fluctuates slightly, it cannot adaptively adjust the pressure, easily causing the patch to crush or resulting in weak lamination. Additionally, the pressure rollers are prone to axial misalignment during adjustment, leading to uneven thickness on the left and right sides of the product.
[0004] Therefore, this utility model proposes a composite production equipment for a transdermal patch sustained-release layer in medicine to overcome the shortcomings of the prior art. Utility Model Content
[0005] To overcome the above deficiencies, this utility model provides a pharmaceutical transdermal patch sustained-release layer composite production equipment, which aims to improve the problems in the existing pharmaceutical transdermal patch production equipment, such as uneven drug mixing leading to unstable product efficacy, and rigid pressure adjustment of composite pressure rollers and lack of buffer protection leading to low product qualification rate.
[0006] To achieve the above objectives, the present invention adopts the following technical solution: a pharmaceutical transdermal patch sustained-release layer composite production equipment, comprising a support body and a fixing plate fixed to the bottom of the support body; a feeding roller, a first transmission shaft, a coating roller, a second transmission shaft, a third transmission shaft, a fixing roller and a winding shaft rotatably connected to the support body; and a stirring assembly and a pressure regulating assembly;
[0007] The stirring assembly includes a stirring tank, a protective shell, and a motor. The motor output is connected to a stirring roller via a drive shaft. Specifically, the stirring roller is equipped with a first scraper and a second scraper. The stirring tank is connected to the coating roller via a pipe. The pressure regulating assembly includes a fixed frame, a hydraulic rod, and a fixed column. The hydraulic rod output is connected to a movable column. The movable column is slidably inserted into the fixed column. A spring is provided inside the fixed column to abut against the movable column. A movable roller is rotatably connected to the movable column.
[0008] Furthermore, the movable roller and the fixed roller are combined in a positional fit, the stirring assembly and the coating roller are connected by the pipeline for fluid transport, and the hydraulic rod achieves flexible drive of the movable roller through the transmission and buffering of the movable column and the spring.
[0009] Preferably, the movable column has grooves on both sides, and the fixed column has a limiting block that slides against the inner wall of the groove. This fit structure restricts the rotational freedom of the movable column, ensuring that the movable roller remains horizontal during lifting and lowering.
[0010] Preferably, the first scraper is fixed to the side of the stirring rod and fits against the inner wall of the mixing tank, and the second scraper is fixed to the bottom of the stirring rod and fits against the bottom of the mixing tank. This arrangement can effectively scrape off materials adhering to the tank wall and deposited at the bottom of the tank, eliminating dead zones in the mixing process.
[0011] Preferably, the mixing tank is provided with an inlet, the protective shell is disposed on the top of the mixing tank, and the motor is disposed inside the protective shell. This structure facilitates the addition of raw materials and provides dust protection for the motor.
[0012] Preferably, the fixing frame is fixed to the support body, the top of the hydraulic rod is fixed inside the fixing frame, and the bottom of the hydraulic rod is connected to the moving column. This connection method provides a stable support foundation for pressure regulation.
[0013] Preferably, the pipe is connected between the mixing tank and the outer wall of the coating roller for conveying the drug to the outer wall of the coating roller.
[0014] Preferably, the two sides of the take-up shaft are fixed inside the support body.
[0015] Preferably, the positions of the feeding roller, the first transmission shaft, and the second transmission shaft are coordinated to convey the material above the second transmission shaft, and the third transmission shaft is positioned behind the coating roller and conveys the material above the fixed roller. This optimized roller layout improves the material transport path and reduces tension fluctuations.
[0016] Preferably, the movable column, driven by the hydraulic rod, drives the movable roller to approach and press against the fixed roller.
[0017] This utility model has the following beneficial effects:
[0018] 1. This utility model solves the problem in the prior art that dead corners are easily generated on the inner wall and bottom of the mixing tank when the drug is mixed with the polymer matrix, resulting in uneven mixing and waste of raw materials. It achieves the technical effect of scraping and lifting the drug attached to the inner wall and bottom of the mixing tank, realizing all-round mixing without dead corners, thereby ensuring the uniformity of the transdermal patch drug composition.
[0019] 2. This utility model, through the structural design of the hydraulic rod driving the moving column in the pressure regulating component and the internal spring abutting, solves the problems of the existing composite pressure roller, which usually adopts rigid connection, has limited pressure adjustment range and lacks buffer, and is prone to damage to transdermal patches due to excessive pressure or uneven composite thickness. It achieves the technical effect of flexibly adjusting the composite pressure according to production needs, using the spring to provide flexible buffer margin, adapting to changes in material thickness, and improving the composite yield.
[0020] 3. This utility model solves the problem in the prior art that the movable pressure roller is prone to circumferential rotation or axial offset during the lifting and lowering adjustment process, resulting in poor parallelism between the upper and lower rollers, by opening sliding grooves on both sides of the movable column and cooperating with the limiting blocks on the fixed column. It achieves the technical effect of accurately guiding and limiting the lifting and lowering of the movable roller, ensuring that the movable roller always keeps parallel and presses against the fixed roller, and ensuring the stability of equipment operation. Attached Figure Description
[0021] Figure 1 This is a perspective view of a pharmaceutical transdermal patch sustained-release layer composite production equipment proposed in this utility model;
[0022] Figure 2 This is a schematic cross-sectional view of the mixing tank of a pharmaceutical transdermal patch sustained-release layer composite production equipment proposed in this utility model;
[0023] Figure 3 for Figure 2 Enlarged view of point A in the middle;
[0024] Figure 4 This is a schematic cross-sectional view of the fixing frame of the pharmaceutical transdermal patch sustained-release layer composite production equipment proposed in this utility model;
[0025] Figure 5 for Figure 4 Enlarged diagram of point B in the middle.
[0026] Legend:
[0027] 1. Support body; 2. Mixing assembly; 3. Discharge roller; 4. First transmission shaft; 5. Coating roller; 6. Second transmission shaft; 7. Third transmission shaft; 8. Moving roller; 9. Pressure regulating assembly; 10. Fixed roller; 11. Rewinding shaft; 12. Fixing plate; 13. Pipeline; 201. Mixing tank; 202. Inlet; 203. Motor; 204. Protective shell; 205. Drive shaft; 206. First scraper; 207. Mixing roller; 208. Second scraper; 901. Fixing frame; 902. Hydraulic rod; 903. Fixing column; 904. Moving column; 905. Slide groove; 906. Limiting block; 907. Spring. Detailed Implementation
[0028] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings of the embodiments. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.
[0029] Reference Figures 1-5 The present invention provides an embodiment of a transdermal patch sustained-release layer composite production equipment for pharmaceutical use, comprising a support body 1 and a fixing plate 12 fixedly connected to the bottom of the support body 1 by bolts. The support body 1 serves as the mounting base for the entire device and provides structural support, while the fixing plate 12 is used to increase the stability of the bottom of the device and facilitate installation and fixing.
[0030] The support body 1 is rotatably connected in sequence according to the material transfer process, including a feeding roller 3, a first transfer shaft 4, a second transfer shaft 6, a coating roller 5, a third transfer shaft 7, a fixed roller 10, and a take-up shaft 11. The feeding roller 3 is used to place the initial substrate roll. The first transfer shaft 4 and the second transfer shaft 6 cooperate to guide the substrate smoothly to the coating station. The coating roller 5 is rotatably connected to the middle of the support body 1 and is used to receive the liquid medicine for coating the substrate. The third transfer shaft 7 is used to transfer the coated wet film substrate to the lamination station. The fixed roller 10 serves as the active or passive support roller for lamination and pressing. The take-up shaft 11 is used to wind and collect the final laminated transdermal patch product.
[0031] It also includes a stirring assembly 2 and a pressure regulating assembly 9. The stirring assembly 2 and the coating roller 5 form a fluid transport connection, and the pressure regulating assembly 9 and the fixed roller 10 form a flexible pressure fit.
[0032] The stirring assembly 2 includes a hollow stirring tank 201. A protective shell 204 is bolted to the center of the top of the stirring tank 201. A motor 203 is fixedly installed inside the protective shell 204. The output shaft of the motor 203 is fixedly connected to a drive shaft 205 via a coupling. The drive shaft 205 vertically penetrates the top wall of the stirring tank 201 and extends into its interior. A stirring rod 207 is fixedly connected to the bottom end of the drive shaft 205. A first scraper 206 is fixedly connected to the outer wall of the stirring rod 207 via screws. The outer edge of plate 206 is in close sliding contact with the inner circumferential wall of mixing tank 201. The bottom end face of stirring rod 207 is fixedly connected to a second scraper 208. The bottom edge of the second scraper 208 is in close sliding contact with the inner bottom wall of mixing tank 201. This structure with side wall scrapers and bottom scrapers can ensure that the drug matrix adhering to the inner wall and precipitated at the bottom is continuously scraped up and circulated during the stirring process, thereby ensuring the uniformity of the drug solution. Mixing tank 201 is connected to coating roller 5 through pipe 13 to realize material supply.
[0033] Meanwhile, the pressure regulating assembly 9 includes a fixed frame 901 fixedly installed on the side wall of the support body 1. A hydraulic rod 902 is fixedly installed inside the fixed frame 901. It also includes a hollow fixed column 903 vertically fixed on the support body 1. The telescopic output end of the hydraulic rod 902 is fixedly connected to a movable column 904. The movable column 904 is slidably inserted into the internal cavity of the fixed column 903. A spring 907 is provided between the inner bottom wall of the fixed column 903 and the bottom end of the movable column 904. The two ends of the spring 907 abut against the inner bottom wall of the fixed column 903 and the bottom surface of the movable column 904, respectively. A movable roller 8 is rotatably connected to the end of the movable column 904 away from the hydraulic rod 902. When the hydraulic rod 902 extends downward, it pushes the movable column 904 to compress the spring 907, causing the movable roller 8 to move closer to the fixed roller 10 and apply pressure. The spring 907 provides a pressure buffer margin to avoid rigid impact crushing the material.
[0034] To ensure the straightness of the lifting and lowering of the movable roller 8, both sides of the movable column 904 are provided with vertically extending grooves 905. The inner wall of the fixed column 903 is correspondingly fixed with a limiting block 906. The limiting block 906 is slidably embedded in the groove 905. This matching structure of the groove 905 and the limiting block 906 ensures that the movable column 904 will not rotate circumferentially during the lifting and lowering pressure adjustment process, and ensures that the axes of the movable roller 8 and the fixed roller 10 always remain parallel.
[0035] In a preferred embodiment, in order to facilitate the addition of raw materials into the mixing tank 201, an injection port 202 is provided on one side of the top of the mixing tank 201. The injection port 202 is directly connected to the internal cavity of the mixing tank 201, and the operator can put the drug powder and polymer matrix into the tank through the injection port 202.
[0036] As another preferred embodiment, in order to ensure that the liquid medicine can be accurately delivered, one end of the pipe 13 is flanged and connected to the bottom outlet of the mixing tank 201, and the other end of the pipe 13 extends and is fixed directly above or to the side of the coating roller 5, for continuously delivering the uniformly mixed fluid medicine to the outer wall surface of the coating roller 5 for coating operation.
[0037] As a preferred embodiment, in order to optimize the material transmission path and ensure tension stability, the positions of the feeding roller 3, the first transmission shaft 4 and the second transmission shaft 6 on the support body 1 are arranged in a stepped or specific angle, so that the material can be lifted and conveyed above the second transmission shaft 6 and then smoothly enter the coating station. The third transmission shaft 7 is located behind the coating roller 5 and is used to support the coated wet material and convey it horizontally above the fixed roller 10 to enter the composite area.
[0038] In a preferred embodiment, in order to achieve dynamic pressure adjustment, the fixed roller 10 is rotatably mounted above the movable roller 8. The hydraulic rod 902 drives the movable column 904 to move in the vertical direction, thereby causing the movable roller 8 to move from bottom to top or from top to bottom, thereby adjusting the gap and contact pressure between the movable roller 8 and the fixed roller 10, and achieving fine adjustment of the thickness of the sustained-release layer composite.
[0039] In a preferred embodiment, in order to ensure the smoothness of winding, the two ends of the winding shaft 11 are rotatably connected between the two inner side walls of the support body 1 through bearing seats, and the winding shaft 11 is connected to a winding motor to provide a constant winding torque.
[0040] Working principle: When using the device to produce a sustained-release layer composite for transdermal patches for pharmaceutical use, the drug and polymer matrix are first put into the mixing tank 201 through the injection port 202, and then the motor 203 inside the protective shell 204 is started.
[0041] When the motor 203 is working, its output end drives the transmission shaft 205 to rotate, which in turn drives the stirring rod 207 inside the mixing tank 201 to rotate. The rotation of the stirring rod 207 fully stirs and mixes the drug and the polymer matrix. During the stirring process, the first scraper 206 fixed on the side of the stirring rod 207 rotates along with it to scrape off the drug adhering to the inner wall of the mixing tank 201. At the same time, the second scraper 208 fixed at the bottom scrapes up the drug at the bottom of the mixing tank 201 to prevent drug residue from causing uneven mixing. The drug after being mixed evenly is transported to the outer wall of the coating roller 5 through the pipe 13.
[0042] At the same time, the feeding roller 3 rotates to release the material. The material is conveyed above the second transmission roller 6 via the first transmission shaft 4 and passes through the coating roller 5. At this time, the drug on the outer wall of the coating roller 5 is evenly coated on the surface of the material. The material coated with the drug continues to be conveyed above the fixed roller 10 via the third transmission shaft 7. At this time, it is necessary to adjust the pressure between the moving roller 8 and the fixed roller 10 to complete the compounding. The hydraulic system inside the hydraulic rod 902 is activated, which drives the moving column 904 at the bottom of the hydraulic rod 902 to move inside the fixed column 903. When the hydraulic rod 902 drives the moving column 904 to move downward, the bottom of the moving column 904 is pushed into the fixed column 903 and squeezes the spring 907 inside the fixed column 903.
[0043] During this process, the moving column 904 drives the moving roller 8 to approach the fixed roller 10, thereby increasing the pressure between the two. At the same time, the sliding grooves 905 on both sides of the moving column 904 cooperate with the limiting blocks 906 on the fixed column 903 to slide, which plays a limiting and guiding role for the moving column 904. Finally, the moving roller 8 cooperates with the fixed roller 10 to press the material and the protective film together. The pressed finished product is then wound up by the winding shaft 11.
Claims
1. A pharmaceutical transdermal patch sustained-release layer composite production equipment, comprising a support body (1) and a fixing plate (12) fixed at the bottom of the support body (1); Rotary connection to the support body (1) includes a feeding roller (3), a first transmission shaft (4), a coating roller (5), a second transmission shaft (6), a third transmission shaft (7), a fixed roller (10), and a take-up shaft (11); characterized in that It also includes a stirring assembly (2) and a pressure regulating assembly (9); The mixing assembly (2) includes a mixing tank (201), a protective shell (204) and a motor (203). The output end of the motor (203) is connected to the mixing roller (207) through a transmission shaft (205). The mixing roller (207) is provided with a first scraper (206) and a second scraper (208). The mixing tank (201) is connected to the coating roller (5) through a pipe (13). The pressure regulating assembly (9) includes a fixed frame (901), a hydraulic rod (902) and a fixed column (903). The output end of the hydraulic rod (902) is connected to a movable column (904). The movable column (904) is slidably inserted into the fixed column (903). A spring (907) is provided in the fixed column (903) to abut against the movable column (904). A movable roller (8) is rotatably connected to the movable column (904). The movable roller (8) is in position with the fixed roller (10).
2. The pharmaceutical transdermal patch sustained-release layer composite production equipment according to claim 1, characterized in that: The movable column (904) has sliding grooves (905) on both sides, and the fixed column (903) has a limiting block (906) which slides in cooperation with the inner wall of the sliding groove (905).
3. The pharmaceutical transdermal patch sustained-release layer composite production equipment according to claim 1, characterized in that: The first scraper (206) is fixed to the side of the stirring rod (207) and fits against the inner wall of the mixing tank (201), and the second scraper (208) is fixed to the bottom of the stirring rod (207) and fits against the bottom of the mixing tank (201).
4. The pharmaceutical transdermal patch sustained-release layer composite production equipment according to claim 1, characterized in that: The mixing tank (201) is provided with an injection port (202), the protective shell (204) is disposed on the top of the mixing tank (201), and the motor (203) is disposed inside the protective shell (204).
5. The pharmaceutical transdermal patch sustained-release layer composite production equipment according to claim 1, characterized in that: The fixed frame (901) is fixed to the support body (1), the top of the hydraulic rod (902) is fixed inside the fixed frame (901), and the bottom of the hydraulic rod (902) is connected to the moving column (904).
6. The pharmaceutical transdermal patch sustained-release layer composite production equipment according to claim 1, characterized in that: The pipe (13) is connected between the mixing tank (201) and the outer wall of the coating roller (5) for conveying the drug to the outer wall of the coating roller (5).
7. The pharmaceutical transdermal patch sustained-release layer composite production equipment according to claim 1, characterized in that: The take-up shaft (11) is fixed inside the support body (1) on both sides.
8. The pharmaceutical transdermal patch sustained-release layer composite production equipment according to claim 1, characterized in that: The positions of the feeding roller (3), the first transmission shaft (4) and the second transmission shaft (6) are coordinated to convey the material to the top of the second transmission shaft (6), and the third transmission shaft (7) is located behind the coating roller (5) and conveys the material to the top of the fixed roller (10).
9. The pharmaceutical transdermal patch sustained-release layer composite production equipment according to claim 2, characterized in that: The movable column (904) drives the movable roller (8) to approach and press against the fixed roller (10) under the drive of the hydraulic rod (902).
